Regional cerebral blood flow in catatonic schizophrenia

Psychiatry Research: Neuroimaging

Volumn 50, Issue 4, 1993, Pages 203-216

  Satoh, Keiji ^a   Suzuki, Teruyasu ^a   Narita, Minoru ^a   Ishikura, Sawako ^a   Shibasaki, Morikazu ^a   Kato, Tadafumi ^a   Takahashi, Saburo ^a   Fukuyama, Hidenao ^b   Ohnishi, Hideo ^a   Morita, Rikushi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

iodoamphetamine; parietal lobe; Single photon emission computed tomography (SPECT)

Indexed keywords

IOFETAMINE I 123;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CATATONIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARIETAL LOBE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AMPHETAMINES; BRAIN MAPPING; CEREBRAL CORTEX; DOMINANCE, CEREBRAL; FEMALE; HUMAN; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; MIDDLE AGE; REGIONAL BLOOD FLOW; SCHIZOPHRENIA, CATATONIC; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0027752750     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4927(93)90001-X     Document Type: Article

References (38)

1. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia
2. Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
3. 3-D segmentation of MR images of the head for 3-D display
4. The deficit syndrome Functional and structural characteristics
5. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia
6. Functional and anatomical brain imaging: Impact on schizophrenia research
7. Cerebral glucography with positron tomography
8. Aspects of stability of regional cerebral blood flow in chronic schizophrenia: An 18-year followup study
9. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia
10. Quantitative iodine-123 IMP imaging of brain perfusion in schizophrenia
11. Increased temporal lobe glucose use in chronic schizophrenic patients
12. Left globus pallidus abnormality in never-medicated patients with schizophrenia
13. Regional brain glucose metabolism in chronic schizophrenia: A positron emission transaxial tomographic study
14. A clinical study of auditory hallucination by single photon emission computed tomography (SPECT) using N-isopropyl-p-[123I] iodoamphetamine (IMP)
15. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia
16. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease
17. Cerebral perfusion imaging in Alzheimer's disease: Use of single photon emission computed tomography and iofetamine hydrochloride I 123
18. 11C-glucose positron emission tomography
19. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression
20. Cerebral blood flow tomography: Xe-133 compared with isopropylamphetamine I-123
21. Surface of the brain: Three-dimensional MR images created with volume rendering
22. A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia
23. Increased accumulation of N-isopropyl-(I-123) p-iodoamphetamine in the left auditory area in a schizophrenic patient with auditory hallucination
24. Quantitative cerebral blood flow measurements using N-isopropyl-(iodine 123) p-iodoamphetamine and single photon emission computed tomography with rotating gamma camera
25. Positron emission tomography and subcortical glucose metabolism in schizophrenia
26. Reduced temporal lobe areas in schizophrenia: Preliminary evidence from a controlled multiplanar magnetic resonance imaging study
27. Altered modulation of prefrontal and subcortical brain activity in newly diagnosed schizophrenia and schizophreniform disorder
28. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
29. Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration
30. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia
31. Positron emission tomography in psychiatry
32. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates
33. Low frontal glucose utilization in chronic schizophrenia: A replication study
34. Persistence of cerebral metabolism abnormalities in chronic schizophrenia as determined by positron emission tomography